Prescriber Resources

Improve Your Patients' Experience

Leverage our resources to educate your patients about medical abortion and what to expect, to help improve adherence and success, and to offer comfort in what may be a stressful time. GenBioPro provides these easy-to-read, patient-friendly “before and after” instructions, or downloadable versions, and in multiple languages, for your use:

Patient Agreement

Because GenBioPro generic mifepristone tablets, 200 mg, are available only under an FDA-approved Risk Evaluation and Mitigation Strategy (REMS) program, a certified prescriber must dispense, supervise dispensing, or write a prescription for the mifepristone to be filled at a certified pharmacy. Before prescribing, certified prescribers must review the Patient Agreement with the patient and secure the patient’s signature on the form. All patients receiving GenBioPro generic mifepristone tablets, 200 mg, for a medical abortion must sign the Patient Agreement.

Medication Guide

GenBioPro generic mifepristone tablets, 200 mg, are only available under an FDA-administered Risk Evaluation and Mitigation Strategy (REMS) program. The REMS program requires that before prescribing a 200 mg generic mifepristone tablet for a medical abortion, certified prescribers review the Medication Guide with the patient. This helps to ensure that patients understand the benefits and risks associated with medical abortion, and how to seek help if needed.

Medical Abortion: Is It Right for You? 

This pamphlet answers the questions typically asked about medical abortion, addressing use, safety, efficacy, and risk. It is designed to help reduce concerns in patients seeking a medical abortion. It also helps patients understand that they are not alone, and that medical abortion is widely practiced to help millions of patients end an early pregnancy in a safe and effective way.

What to Expect Guide

This guide reviews how the two medical abortion drugs are administered, timing, possible side effects, and the follow-up care. It also covers symptoms that require prompt attention, and what the patient should do in that event. This simple, graphic guide is a companion piece to the Patient Agreement and Medication Guide.

Good News for Patients

This brochure explains the 2023 changes to the REMS guidelines for generic mifepristone tablets, 200 mg, and what they mean for patients.

Taking Your Pills

This easy-to-understand, illustrated guide walks patients step-by-step through the process for taking their generic mifepristone tablet, 200 mg, followed by the four misoprostol tablets. It covers how and when to take the pills, what patients can expect in the following weeks, and the follow-up appointment with the health care provider.

When to Call Us

This illustrated, patient-friendly guide provides information about common side effects of mifepristone and misoprostol, what normal bleeding and cramping to expect, and what symptoms require immediate care from the health care provider. It provides space for health care providers to add their phone number.

How Much Am I Bleeding?

Using illustrations as a reference point, this straightforward guide helps patients understand what very light, light, moderate, and heavy bleeding over the course of one hour look like on a sanitary pad.

Need More Information

Contact us if you have more questions about mifepristone, becoming a certified GenBioPro prescriber, ordering product, or to request additional copies of the full prescribing information or other resources:

Online | 1-855-MIFEINFO (1-855-643-3463) |